PATENT
EP3129044
PEPTIDOGLYCAN HYDROLASE FOR USE IN THE TREATMENT OF CHRONIC BACTERIAL INFECTIONS
EPO Register
Applicant(s)
Lysando AG
Status
The patent has been granted
Status date
2022-08-05
Opposition filed
2023-06-09
Revocation communicated
2024-12-05
Appeal filed
2025-02-05
Appeal decision
2026-11-04
Latest register event
2026-11-04
Family
50439296
Source: EPO Open Patent Services (epo-ops).
Court proceedings (1)
- 2026-10-28Lysando AG v. Gleiss Große Schrell und Partner mbB, Strawman Limited